PT  - JOURNAL ARTICLE
AU  - Gianna Camiciottoli
AU  - Francesca Bigazzi
AU  - Valentina Luzzi
AU  - Elena Torricelli
AU  - Matteo Vannini
AU  - Alessio Garcea
AU  - Lorenzo Corsi
AU  - Matteo Paoletti
AU  - Lucia Cestelli
AU  - Massimo Pistolesi
TI  - Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
DP  - 2013 Sep 01
TA  - European Respiratory Journal
PG  - P3680
VI  - 42
IP  - Suppl 57
4099  - http://erj.ersjournals.com/content/42/Suppl_57/P3680.short
4100  - http://erj.ersjournals.com/content/42/Suppl_57/P3680.full
SO  - Eur Respir J2013 Sep 01; 42
AB  - COPD is a heterogeneous disorder with extrapulmonary manifestations. Multivariate models based on sputum features and whole lung function allow patients to be classified in a graph whose coordinates CT1and CT2 reflect COPD phenotype and severity as assessed by CT (Camiciottoli,G et al. ERJ in press). Phenotypic characteristics range progressively from airway predominant (AP)(CT1-) to emphysema predominant (EP)(CT1+). Severity of COPD increases progressively from CT2- to CT2+. In 242 COPD patients we assessed prevalence of Hypertension(H), Coronary Artery Disease(CAD), Peripheral Arterial Disease(PAD), Heart failure(HF), Diabetes(D),Osteoporosis(O), and Psychological Disorders(PD).We compared prevalence among subsets partitioned according to COPD phenotype and severityView this table:View this table:Cardiovascular comorbidities are very common in COPD, with the highest prevalence in milder disease (CT2-) irrespective of the phenotype,suggesting that COPD severity progression is allowed to patients without concomitant cardiovascular comorbidity. These data support recent findings of excess mortality in GOLD B with respect to GOLD C patients and underline the need to suspect,diagnose and treat cardiovascular comorbidities in early stages of COPD.